Recurrent growth factor starvation promotes drug resistance in human leukaemic cells

British Journal of Cancer

Volumn 86, Issue 2, 2002, Pages 292-300

  Saeki, K ^a   Okuma, E ^a   Yuo, Akira ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

GM CSF; Leukaemia; MO7e; Multi drug resistance

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR; HEAT SHOCK PROTEIN 70; LIGAND; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CLONING; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MALNUTRITION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STARVATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HUMANS; LEUKEMIA; LIGANDS; NUTRITION DISORDERS; ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0037148458     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600036     Document Type: Article

References (27)

1. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
2. M-07e human leukaemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3
3. Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day
4. Short-term remission induction and consolidation therapy for adult acute myelogenous leukaemia
5. Cumulative bone marrow stromal damage caused by X-irradiation and cytosine-arabinoside in mice
6. Chromosomal staining and banding
7. Human acute myeloid leukaemia CD34+/CD38-progenitor calls have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities
8. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle
9. Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix
10. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells
11. Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity
12. High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukaemia
13. Mammalian stress response: Induction of the glucose-regulated protein family
14. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro
15. Changes in susceptibility to Fas-mediated apoptosis during differentiation of HL-60 cells
16. Induction of apoptosis in human hematopoietic U937 cells by granulocyte-macrophage colony-stimulating factor: Possible existence of caspase 3-like pathway
17. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
18. Novel mechanisms of drug resistance in leukaemia
19. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor β1 and overexpression of Bcl-2
20. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukaemic HL60 cells
21. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells
22. Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response
23. Oxidative stress as a necessary factor in room temperature-induced apoptosis of HL-60 cells
24. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs
25. Glucose-regulated stresses induce resistance to camptothecin in human cancer cells
26. Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II
27. Glutathione-related mechanisms in cellular resistance to anticancer drugs